| Improved adherence rates and clinical outcomes of an integrated, closed-loop, pharmacist-led oral chemotherapy management program B Muluneh, M Schneider, A Faso, L Amerine, R Daniels, B Crisp, J Valgus, ... Journal of oncology practice 14 (6), e324-e334, 2018 | 87 | 2018 |
| 2018 Hematology/Oncology Pharmacist Association best practices for the management of oral oncolytic therapy: pharmacy practice standard E Mackler, EM Segal, B Muluneh, K Jeffers, J Carmichael Journal of oncology practice 15 (4), e346-e355, 2019 | 75 | 2019 |
| Left ventricular dysfunction after treatment with ipilimumab for metastatic melanoma ME Roth, B Muluneh, BC Jensen, C Madamanchi, CB Lee American journal of therapeutics 23 (6), e1925-e1928, 2016 | 60 | 2016 |
| Patient perspectives on the barriers associated with medication adherence to oral chemotherapy B Muluneh, A Deal, MD Alexander, MD Keisler, JM Markey, JM Neal, ... Journal of Oncology Pharmacy Practice 24 (2), 98-109, 2018 | 56 | 2018 |
| Impact of an integrated oral chemotherapy program on patient adherence KP Morgan, B Muluneh, AM Deal, LB Amerine Journal of Oncology Pharmacy Practice 24 (5), 332-336, 2018 | 39 | 2018 |
| Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient B Muluneh, A Dean, P Armistead, T Khan Journal of oncology pharmacy practice 19 (2), 181-185, 2013 | 28 | 2013 |
| Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: a cautionary tale T Trantham, J Auten, B Muluneh, H Van Deventer Journal of Oncology Pharmacy Practice 26 (4), 1005-1008, 2020 | 26 | 2020 |
| Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics A Mitchell, B Muluneh, R Patel, E Basch Journal of Oncology Pharmacy Practice 24 (6), 424-432, 2018 | 23 | 2018 |
| Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: a retrospective analysis of real world patients MS Yazdy, AR Mato, LE Roeker, U Jarral, CS Ujjani, M Shadman, ... Blood 134, 4311, 2019 | 21 | 2019 |
| Comparative safety and health care expenditures among patients with chronic myeloid leukemia initiating first-line imatinib, dasatinib, or nilotinib AL Cole, WA Wood Jr, B Muluneh, JL Lund, J Elston Lafata, SB Dusetzina JCO Oncology Practice 16 (5), e443-e455, 2020 | 19 | 2020 |
| A pharmacist-led oral chemotherapy program's impact on chronic myeloid leukemia patient satisfaction, adherence, and outcomes T Dennison, AM Deal, M Foster, J Valgus, B Muluneh Journal of the Advanced Practitioner in Oncology 12 (2), 148, 2021 | 17 | 2021 |
| Venetoclax‐induced tumour lysis syndrome in acute myeloid leukaemia S Esparza, B Muluneh, J Galeotti, M Matson, DR Richardson, ... British journal of haematology 188 (1), 173-177, 2020 | 16 | 2020 |
| Vemurafenib‐A ssociated P ancreatitis: C ase R eport B Muluneh, LW Buie, F Collichio Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (4 …, 2013 | 16 | 2013 |
| Interpersonal communication-, education-and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review J Elston Lafata, B Nguyen, C Staresinic, M Johnson, D Gratie, B Muluneh Journal of Oncology Pharmacy Practice 29 (2), 358-369, 2023 | 13 | 2023 |
| Obstacles to affordable cancer treatments SB Dusetzina, B Muluneh, T Khan, KL Richards, NL Keating North Carolina Medical Journal 75 (4), 257-260, 2014 | 12 | 2014 |
| Broken promises-how Medicare part D has failed to deliver savings to older adults SB Dusetzina, B Muluneh, NL Keating, HA Huskamp The New England journal of medicine 383 (24), 2299-2301, 2020 | 11 | 2020 |
| Trials and tribulations of corrected QT interval monitoring in oncology: rationale for a Practice-Changing standardized approach B Muluneh, DR Richardson, C Hicks, BC Jensen, JF Zeidner Journal of Clinical Oncology 37 (30), 2719-2721, 2019 | 11 | 2019 |
| Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation JS Bates, J Auten, MR Sketch, T Patel, SM Clark, KP Morgan, B Muluneh, ... Journal of Oncology Pharmacy Practice 25 (4), 896-902, 2019 | 11 | 2019 |
| Blood pressure control in patients receiving bevacizumab in an outpatient cancer center S Bottiglieri, B Muluneh, S Sutphin, L Iacovelli, V Adams Journal of Oncology Pharmacy Practice 17 (4), 333-338, 2011 | 11 | 2011 |
| ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications SM Belcher, E Mackler, B Muluneh, PK Ginex, MK Anderson, ... Oncology nursing forum 49 (4), 279, 2022 | 10 | 2022 |
